Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults

scientific article

Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.3233/JAD-148009
P8608Fatcat IDrelease_rlcnnab4dbeupmtysjnvmek4ji
P932PMC publication ID4398648
P698PubMed publication ID25690665

P50authorAlexander NiculescuQ4719749
Alzheimer's Disease Neuroimaging InitiativeQ4738819
Tatiana ForoudQ28516692
Andrew J. SaykinQ30514182
Shannon L. RisacherQ87217788
Kwangsik NhoQ87614152
Sungeun KimQ61072086
Martin R. FarlowQ67212573
Brenna C. McDonaldQ87217754
P2093author name stringVijay K Ramanan
Christopher M Callahan
Hugh C Hendrie
Emrin Horgusluoglu
Mark H Inlow
P2860cites workA Swedish National Twin Study of Lifetime Major DepressionQ22306276
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn DiseaseQ24644398
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeuticsQ24685475
Principal components analysis corrects for stratification in genome-wide association studiesQ27860975
The glutamate receptor ion channelsQ28137916
Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7Q28507609
Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7Q28585707
A genome-wide association study of depressive symptomsQ28943434
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetesQ29417138
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortQ29417147
Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7Q30402875
The genetics of major depression: moving beyond the monoamine hypothesisQ33669125
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plansQ33846034
Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Q33874459
Molecular frequency filters at central synapsesQ33927927
Gene-based tests of associationQ33987507
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learnedQ34147518
Pathway analysis of genomic data: concepts, methods, and prospects for future developmentQ34223263
Targeting of NMDA receptors in the treatment of major depressionQ34397015
Depression in the elderlyQ34423873
Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorderQ34507224
Activation of the mGlu7 receptor elicits antidepressant-like effects in miceQ34648343
Meta-analyses of genetic studies on major depressive disorderQ34701323
Depression and anxiety symptoms in male veterans and non-veterans: the Health and Retirement StudyQ35108966
A conserved BDNF, glutamate- and GABA-enriched gene module related to human depression identified by coexpression meta-analysis and DNA variant genome-wide association studiesQ35114644
Neuropsychiatric symptoms in Alzheimer's diseaseQ35823575
Plasma biomarkers of depressive symptoms in older adultsQ35844316
The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysisQ36110161
A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking familiesQ36206875
HYST: a hybrid set-based test for genome-wide association studies, with application to protein-protein interaction-based association analysisQ36439328
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysisQ36465225
Genome-wide pathway analysis of memory impairment in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort implicates gene candidates, canonical pathways, and networksQ37019930
Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizersQ37159843
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairmentQ37183109
Genome-wide association analysis of copy number variation in recurrent depressive disorder.Q37611740
Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?Q37811712
A new lead from genetic studies in depressed siblings: assessing studies of chromosome 3.Q37911082
A breach in the scaffold: the possible role of cytoskeleton dysfunction in the pathogenesis of major depressionQ38045080
Role of lithium augmentation in the management of major depressive disorderQ38192967
The importance of cytokines and autoantibodies in depressionQ38252994
Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 ExpressionQ40989548
Acute antidepressant treatment differently modulates ERK/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex.Q42517899
Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood InstituteQ42620853
Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjectsQ43594315
Cytokine-associated emotional and cognitive disturbances in humansQ43601371
A genome-wide significant linkage for severe depression on chromosome 3: the depression network studyQ43756830
Genetic susceptibility to accelerated cognitive decline in the US Health and Retirement StudyQ45826128
Total ERK1/2 activity regulates cell proliferationQ46109721
Longitudinal changes in the contribution of genetic and environmental influences to symptoms of depression in older male twinsQ46211862
Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonistsQ46708934
Maintenance treatment with fluoxetine is necessary to sustain normal levels of synaptic markers in an experimental model of depression: correlation with behavioral responseQ46936548
Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic studyQ48487757
Gender differences in heritability of depressive symptoms in the elderly.Q51993964
Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7.Q52007247
Linkage to 20p13 including the ANGPT4 gene in families with mixed Alzheimer's disease and vascular dementia.Q53413550
Variants in Apaf-1 segregating with major depression promote apoptosome function.Q53611851
Minority perspectives from the Health and Retirement Study. Introduction: health and retirement among ethnic and racial minority groups.Q53622888
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.Q54027114
Role of shared genetic and environmental factors in symptoms of depression and body compositionQ57309112
LYMPHOKINE RELEASE FROM HUMAN LYMPHOMONONUCLEAR CELLS AFTER CO-CULTURE WITH ISOLATED PANCREATIC ISLETS: EFFECTS OF ISLET SPECIES, LONG-TERM CULTURE, AND MONOCYTE-MACROPHAGE CELL REMOVALQ57504397
Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depressionQ80996268
P433issue4
P304page(s)1197-1206
P577publication date2015-01-01
P1433published inJournal of Alzheimer's DiseaseQ6294755
P1476titleComprehensive gene- and pathway-based analysis of depressive symptoms in older adults
P478volume45

Reverse relations

cites work (P2860)
Q97643162A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer's disease
Q91620808Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
Q48066803Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know?
Q98384889Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics
Q39301735From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms
Q64963702GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.
Q26801647Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Q40353484Genome-wide Regional Heritability Mapping Identifies a Locus Within the TOX2 Gene Associated With Major Depressive Disorder
Q38376090Genome-wide association study of language performance in Alzheimer's disease
Q26778022Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer
Q42696742Mood, stress and longevity: convergence on ANK3.
Q90295915Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients
Q37183072Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
Q52576146SALM/Lrfn Family Synaptic Adhesion Molecules.
Q38658765Stress, depression, resilience and ageing: A role for the LPA-LPA1 pathway.
Q38768169The psychosis spectrum in Parkinson disease

Search more.